Eko Analysis Software vs AI-CVD

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Eko Analysis Software
by Eko Devices
VS
AI-CVD
by HeartLung AI

AI Verdict

Tool A focuses on real-time, point-of-care detection of heart murmurs and atrial fibrillation using digital stethoscopes and ECGs. In contrast, Tool B performs opportunistic screening for a broader range of cardiovascular risks by analyzing existing CT scans. While both are FDA-cleared AI tools for cardiovascular disease detection, their distinct input modalities and specific diagnostic focuses make them complementary rather than direct competitors.

Choose Eko Analysis Software if…

Choose Eko Analysis Software if you need an AI-powered solution for real-time cardiovascular assessment during patient encounters or remote monitoring. This tool is ideal for clinicians performing auscultation and ECGs, seeking immediate AI assistance in detecting heart murmurs and atrial fibrillation, and requiring secure storage and sharing of these recordings.

View Eko Analysis Software →

Choose AI-CVD if…

Choose AI-CVD if your primary goal is opportunistic screening for cardiovascular and multisystem diseases using existing CT scans. This platform is best suited for healthcare systems looking to leverage previously acquired chest or abdominal CT data to identify hidden health risks like coronary artery calcium and aortic calcification without requiring additional imaging or patient visits.

View AI-CVD →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Analysis Software AI-CVD
Pricing Freemium with subscription for full features Unknown
Deployment Cloud-based Unknown
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Unknown
HIPAA Yes AI-estimated Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Analysis Software AI-CVD
Tool Name Eko Analysis Software AI-CVD
Company Eko Devices HeartLung Corporation
Tagline Your new partner in precise, proactive heart and lung care. Advancing AI-enabled, CT-based opportunistic screening and early disease detection.
Key Features FDA-cleared AI for heart murmur detection, FDA-cleared AI for atrial fibrillation (AFib) detection, Detection of normal sinus rhythm, Calculation of cardiac time intervals (heart rate, QRS duration), Wireless auscultation with Bluetooth-enabled devices, Recording, playback, and annotation of heart sounds and ECGs, Visualization of phonocardiograms (PCG) and ECG tracings, Secure cloud-based storage of recordings within the US. Automated CT-derived anatomical and density-based measurements, Opportunistic screening from existing chest and abdominal CT scans, No additional imaging, radiation, contrast, or workflow disruption, Coronary Artery Calcium (CAC) scoring, Aortic wall, aortic valve, and mitral valve calcium analysis, Cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle), Epicardial fat volumetry, Aorta and pulmonary artery sizing.
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Eko Analysis Software and AI-CVD.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Eko Analysis Software integrates with Eko's digital stethoscopes and mobile app to analyze heart sounds and ECGs. AI-CVD, on the other hand, performs opportunistic screening using existing chest and abdominal CT scans.
Eko Analysis Software is designed for point-of-care use, assisting clinicians in real-time during physical exams or telehealth appointments. AI-CVD integrates into a workflow by analyzing already acquired CT scans, without requiring additional imaging or workflow disruption.
Eko Analysis Software is FDA-cleared for the detection of heart murmurs, atrial fibrillation (AFib), and normal sinus rhythm, and also calculates cardiac time intervals. AI-CVD provides automated CT-derived measurements including Coronary Artery Calcium (CAC) scoring, aortic and mitral valve calcium analysis, cardiac chamber volumetry, epicardial fat volumetry, and aorta and pulmonary artery sizing.
Eko Analysis Software uses non-invasive digital stethoscopes and a mobile app, so it does not require additional patient procedures or radiation. AI-CVD performs opportunistic screening from *existing* CT scans, meaning no additional imaging, radiation, or contrast is needed beyond the initial CT scan.
Eko Analysis Software is primarily designed for Cardiology, Emergency Medicine, and Internal Medicine. AI-CVD is targeted towards Cardiology, Pulmonology, and Radiology specialties.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Eko Analysis Software or AI-CVD

Backers

Who funded each tool's parent company.

Eko Analysis Software

AI Tool Finder
AI-powered search. Results may not be comprehensive.